Por favor, espera, estamos cargando datos de gráficos
AbbVie Inc comunidad
About AbbVie Inc
What is AbbVie Inc?
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
The current price of AbbVie Inc in the market is 198,51 $, with a 24-hour trading volume of 1,07B $. The asset's market cap is 351,11B $, after moving -1.11% in the last day.
Tokenized AbbVie Inc is trading at 200,87 $, with a tokenized market cap of 13,62M $ and a 24-hour trading volume of 943,12K $. The tokenized asset has moved -2.88% in the past 24 hours.